Raw clays from Morocco for degradation of pollutants by Fenton-like reaction for water treatment

Three raw clays from Morocco were used as heterogeneous catalysts for Fenton-like oxidation of organic pol-lutants in water. The selected pollutants were two dyes used in the textile industry, Congo Red (CR) and Tar-trazine (Tar, known also as a food coloring compound, E102) and Caffeine (Caf), a stimulant drug present in popular beverages such as coffee and tea, commonly used in Morocco. Two different processes were used for their degradation: (i) Fenton-like reaction; and (ii) electro-Fenton-like reaction. Process (i) was used for Tar and Caf degradation in the presence of clays from different region of Morocco (Middle Atlas -ClayMA, Fez -ClayF, and Ourika -ClayO), the best results being obtained with ClayO and ClayMA, on which 60.0% and 23.4% of conversion and 41.0% and 20.5% of mineralization were achieved for Tar and Caf, respectively. Process (ii) was used for degrading CR by clay-modified electrodes (CME) using the rawclays from Fez and Ourika regions (ClayF and ClayO). The stability of the CME was assessed by cyclic voltammetry studies, which proved that they are stable in the experimental conditions used. The electrodegradation of CR dye, performed without hydrogen peroxide in the reaction medium, achieve 67.0% of mineralization at the end of electrolysis (2 h)

De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal development

Bosma arhinia microphthalmia syndrome (BAMS) is an extremely rare and striking condition characterized by complete absence of the nose with or without ocular defects. We report here that missense mutations in the epigenetic regulator SMCHD1 mapping to the extended ATPase domain of the encoded protein cause BAMS in all 14 cases studied. All mutations were de novo where parental DNA was available. Biochemical tests and in vivo assays in Xenopus laevis embryos suggest that these mutations may behave as gain-of-function alleles. This finding is in contrast to the loss-of-function mutations in SMCHD1 that have been associated with facioscapulohumeral muscular dystrophy (FSHD) type 2. Our results establish SMCHD1 as a key player in nasal development and provide biochemical insight into its enzymatic function that may be exploited for development of therapeutics for FSHD

Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome

Aims: Chronic hyperglycaemia, assessed by elevated glycated haemoglobin (A1C), is a known risk factor for heart failure (HF) and cardiovascular (CV) death among subjects with diabetes. Whether this risk varies with left ventricular ejection fraction (LVEF) is unknown. This study evaluated whether A1C influences a composite outcome of either HF hospitalization or CV death differently along the spectrum of LVEF. Methods and results: We assessed the relationships of baseline A1C and LVEF with a composite outcome of either CV death or HF hospitalization in the 4091 patients with type 2 diabetes and a recent acute coronary syndrome enrolled in the ELIXA trial who had available LVEF. We assessed for interaction between A1C and LVEF as continuous variables with respect to this outcome. During a median follow‐up of 25.7 months, 343 patients (8.4%) had HF hospitalization or died of CV causes. In a multivariable model, A1C and LVEF were each associated with an increased risk of HF hospitalization or CV death [adjusted hazard ratio (HR) 1.11, 95% confidence interval (CI) 1.01–1.21 per 1% higher A1C, and adjusted HR 1.39, 95% CI 1.27–1.51 per 10% lower in LVEF]. Both A1C and LVEF were independently and incrementally associated with risk without evidence of interaction (P for interaction = 0.31). Patients with A1C ≥ 8% and LVEF <40% were at threefold higher risk than those with A1C < 7% and LVEF ≥50% (adjusted HR 3.18, 95% CI 2.03–4.98, P < 0.001). Conclusion: In a contemporary cohort of patients with type 2 diabetes and acute coronary syndrome, baseline chronic hyperglycaemia was associated with an increased risk of HF hospitalization or CV death independently of LVEF

Investigating Pneumonia Etiology Among Refugees and the Lebanese population (PEARL): A study protocol

Background: Community-acquired pneumonia (CAP), a leading cause of mortality, mainly affects children in developing countries. The harsh circumstances experienced by refugees include various factors associated with respiratory pathogen transmission, and clinical progression of CAP. Consequently, the etiology of CAP in humanitarian crisis situations may differ to that of settled populations, which would impact appropriate case management. Therefore, the Pneumonia Etiology Among Refugees and the Lebanese population (PEARL) study was initiated with the objective of identifying the causal pathogenic microorganisms in the respiratory tract of children and adults from both the refugee and host country population presenting with signs of CAP during a humanitarian crisis. Methods: PEARL, a prospective, multicentric, case-control study, will be conducted at four primary healthcare facilities in Tripoli and the Bekaa valley over 15 months (including two high-transmission seasons/winters). Sociodemographic and medical data, and biological samples will be collected from at least 600 CAP cases and 600 controls. Nasopharyngeal swabs, sputum, urine and blood samples will be analyzed at five clinical pathology laboratories in Lebanon to identify the bacterial and viral etiological agents of CAP. Transcriptomic profiling of host le

Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09‐related pneumonia: an individual participant data meta‐analysis

BACKGROUND: The impact of neuraminidase inhibitors (NAIs) on influenza‐related pneumonia (IRP) is not established. Our objective was to investigate the association between NAI treatment and IRP incidence and outcomes in patients hospitalised with A(H1N1)pdm09 virus infection. METHODS: A worldwide meta‐analysis of individual participant data from 20 634 hospitalised patients with laboratory‐confirmed A(H1N1)pdm09 (n = 20 021) or clinically diagnosed (n = 613) ‘pandemic influenza’. The primary outcome was radiologically confirmed IRP. Odds ratios (OR) were estimated using generalised linear mixed modelling, adjusting for NAI treatment propensity, antibiotics and corticosteroids. RESULTS: Of 20 634 included participants, 5978 (29·0%) had IRP; conversely, 3349 (16·2%) had confirmed the absence of radiographic pneumonia (the comparator). Early NAI treatment (within 2 days of symptom onset) versus no NAI was not significantly associated with IRP [adj. OR 0·83 (95% CI 0·64–1·06; P = 0·136)]. Among the 5978 patients with IRP, early NAI treatment versus none did not impact on mortality [adj. OR = 0·72 (0·44–1·17; P = 0·180)] or likelihood of requiring ventilatory support [adj. OR = 1·17 (0·71–1·92; P = 0·537)], but early treatment versus later significantly reduced mortality [adj. OR = 0·70 (0·55–0·88; P = 0·003)] and likelihood of requiring ventilatory support [adj. OR = 0·68 (0·54–0·85; P = 0·001)]. CONCLUSIONS: Early NAI treatment of patients hospitalised with A(H1N1)pdm09 virus infection versus no treatment did not reduce the likelihood of IRP. However, in patients who developed IRP, early NAI treatment versus later reduced the likelihood of mortality and needing ventilatory support

Nucleant layer effect on nanocolumnar ZnO films grown by electrodeposition

Different ZnO nanostructured films were electrochemically grown, using an aqueous solution based on ZnCl2, on three types of transparent conductive oxides grow on commercial ITO (In2O3:Sn)-covered glass substrates: (1) ZnO prepared by spin coating, (2) ZnO prepared by direct current magnetron sputtering, and (3) commercial ITO-covered glass substrates. Although thin, these primary oxide layers play an important role on the properties of the nanostructured films grown on top of them. Additionally, these primary oxide layers prevent direct hole combination when used in optoelectronic devices. Structural and optical characterizations were carried out by scanning electron microscopy, atomic force microscopy, and optical transmission spectroscopy. We show that the properties of the ZnO nanostructured films depend strongly on the type of primary oxide-covered substrate used. Previous studies on different electrodeposition methods for nucleation and growth are considered in the final discussion.We thank Prof. A. Segura of the Universitat de Valencia for the facilities with the sputtering equipment. This work was supported by the project PROMETEO/2009/074 from the Generalitat Valenciana.Reyes Tolosa, MD.; Damonte, LC.; Brine, H.; Bolink, HJ.; Hernández Fenollosa, MDLÁ. (2013). Nucleant layer effect on nanocolumnar ZnO films grown by electrodeposition. Nanoscale Research Letters. 8:135-144. https://doi.org/10.1186/1556-276X-8-135S1351448Franklin JB, Zou B, Petrov P, McComb DW, Ryanand MP, McLachlan MA,J: Optimised pulsed laser deposition of ZnO thin films on transparent conducting substrates. Mater Chem 2011, 21: 8178–8182. 10.1039/c1jm10658aJaroslav B, Andrej V, Marie N, Šuttab P, Miroslav M, František U: Cryogenic pulsed laser deposition of ZnO. Vacuum 2012, 86(6):684–688. 10.1016/j.vacuum.2011.07.033Jae Bin L, Hyeong Joon K, Soo Gil K, Cheol Seong H, Seong-Hyeon H, Young Hwa S, Neung Hun L: Deposition of ZnO thin films by magnetron sputtering for a film bulk acoustic resonator. Thin Solid Films 2003, 435: 179–185. 10.1016/S0040-6090(03)00347-XXionga DP, Tanga XG, Zhaoa WR, Liua QX, Wanga YH, Zhoub SL: Deposition of ZnO and MgZnO films by magnetron sputtering. Vacuum 2013, 89: 254–256.Reyes Tolosa MD, Orozco-Messana J, Lima ANC, Camaratta R, Pascual M, Hernandez-Fenollosa MA: Electrochemical deposition mechanism for ZnO nanorods: diffusion coefficient and growth models. J Electrochem Soc 2011, 158(11):E107-E110.Ming F, Ji Z: Mechanism of the electrodeposition of ZnO nanosheets below room temperature. J Electrochem Soc 2010, 157(8):D450-D453. 10.1149/1.3447738Pullini D, Pruna A, Zanin S, Busquets Mataix D: High-efficiency electrodeposition of large scale ZnO nanorod arrays for thin transparent electrodes. J Electrochem Soc 2012, 159: E45-E51. 10.1149/2.093202jesPruna A, Pullini D, Busquets Mataix D: Influence of deposition potential on structure of ZnO nanowires synthesized in track-etched membranes. J Electrochem Soc 2012, 159: E92-E98. 10.1149/2.003205jesMarotti RE, Giorgi P, Machado G, Dalchiele EA: Crystallite size dependence of band gap energy for electrodeposited ZnO grown at different temperatures. Solar Energy Materials and Solar Cells 2009, 90(15):2356–2361.Yeong Hwan K, Myung Sub K, Jae Su Y: Structural and optical properties of ZnO nanorods by electrochemical growth using multi-walled carbon nanotube-composed seed layers. Nanoscale Res Lett 2012, 7: 13. 10.1186/1556-276X-7-13Elias J, Tena-Zaera R, Lévy-Clément C: Electrodeposition of ZnO nanowires with controlled dimensions for photovoltaic applications: role of buffer layer. Thin Solid Films 2007, 515(24):8553–8557. 10.1016/j.tsf.2007.04.027Zhai Y, Zhai S, Chen G, Zhang K, Yue Q, Wang L, Liu J, Jia J: Effects of morphology of nanostructured ZnO on direct electrochemistry and biosensing properties of glucose oxidase. J Electroanal Chem 2011, 656: 198–205. 10.1016/j.jelechem.2010.11.020Reyes Tolosa MD, Orozco-Messana J, Damonte LC, Hernandez-Fenollosa MA: ZnO nanoestructured layers processing with morphology control by pulsed electrodeposition. J Electrochem Soc 2011, 158(7):D452-D455. 10.1149/1.3593004Gouxa A, Pauporté T, Chivot J, Lincot D: Temperature effects on ZnO electrodeposition. Electrochim Acta 2005, 50(11):2239–2248. 10.1016/j.electacta.2004.10.007Kwok WM, Djurisic , Aleksandra B, Leung , Yu H, Li D, Tam KH, Phillips DL, Chan WK: Influence of annealing on stimulated emission in ZnO nanorods. Appl Phys Lett 2006, 89(18):183112. 183112–3 183112–3 10.1063/1.2378560Donderis V, Hernández-Fenollosa MA, Damonte LC, Marí B, Cembrero J: Enhancement of surface morphology and optical properties of nanocolumnar ZnO films. Superlattices and Microstructures 2007, 42: 461–467. 10.1016/j.spmi.2007.04.068Ghayour H, Rezaie HR, Mirdamadi S, Nourbakhsh AA: The effect of seed layer thickness on alignment and morphology of ZnO nanorods. Vacuum 2011, 86: 101–105. 10.1016/j.vacuum.2011.04.025Michael B, Mohammad Bagher R, Sayyed-Hossein K, Wojtek W, Kourosh K-z: Aqueous synthesis of interconnected ZnO nanowires using spray pyrolysis deposited seed layers. Mater Lett 2010, 64: 291–294. 10.1016/j.matlet.2009.10.065Jang Bo S, Hyuk C, Sung-O K: Rapid hydrothermal synthesis of zinc oxide nanowires by annealing methods on seed layers. J Nanomater 2011, 2011: 6.Peiro AM, Punniamoorthy R, Kuveshni G, Boyle DS, Paul O’B, Donal DC, Bradley , Jenny N, Durrant JR: Hybrid polymer/metal oxide solar cells based on ZnO columnar structures. J Mater Chem 2006, 16(21):2088–2096. 10.1039/b602084dVallet-Regí M, Salinas AJ, Arcos D: From the bioactive glasses to the star gels. J Mater Sci Mater Med 2006, 17: 1011–1017.Peulon S, Lincot D: Mechanistic study of cathodic electrodeposition of zinc oxide and zinc hydroxychloride films from oxygenated aqueous zinc chloride solutions. J Electrochem Soc 1998, 145: 864. 10.1149/1.1838359Dalchiele EA, Giorgi P, Marotti RE, Martín F, Ramos-Barrado JR, Ayouci R, Leinen D: Electrodeposition of ZnO thin films on n-Si(100). Sol. Energy Mater. Sol. Cells 2001, 70: 245. 10.1016/S0927-0248(01)00065-4Courtney IA, Dahn JR: Electrochemical and in situ X‐ray diffraction studies of the reaction of lithium with tin oxide composites. J Electrochem Soc 1997, 144(6):2045–2052. 10.1149/1.183774

β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer

Consistent with their essential role in cell adhesion to the extracellular matrix, integrins and their associated signaling pathways have been shown to be involved in cell proliferation, migration, invasion and survival, processes required in both tumorigenesis and metastasis. β1-integrins represent the predominantly expressed integrins in mammary epithelial cells and have been proven crucial for mammary gland development and differentiation. Here we provide an overview of the studies that have used transgenic mouse models of mammary tumorigenesis to establish β1-integrin as a critical mediator of breast cancer progression and thereby as a potential therapeutic target for the development of new anticancer strategies

Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome : Insights from the LUNG SAFE study

Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Background: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ≥ 0.60 during hyperoxemia). Results: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47). Conclusions: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073publishersversionPeer reviewe